Response Genetics (RGDXQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 7,050 | N/A | 17,020 | N/A |
| Receivables | 1,980 | N/A | 4,200 | N/A |
| Other current assets | 420 | 400 | 570 | 0 |
| TOTAL | $9,450 | $400 | $21,790 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 1,250 | N/A | 2,590 | N/A |
| Other Non-Current Assets | 80 | 60 | 20 | 0 |
| TOTAL | $1,330 | $60 | $2,610 | $N/A |
| Total Assets | $10,790 | $460 | $24,410 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 720 | 540 | 230 | 0 |
| Accrued Expenses | 1,420 | 1,190 | 1,090 | N/A |
| Other current liabilities | 2,590 | 2,580 | 7,190 | N/A |
| TOTAL | $4,750 | $4,310 | $8,510 | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 3,970 | 0 | 0 | 0 |
| TOTAL | $5,380 | $2,350 | $790 | $N/A |
| Total Liabilities | $10,140 | $6,660 | $9,300 | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 150 | 100 | 100 | N/A |
| Retained earnings | -39,140 | N/A | -20,320 | N/A |
| Other shareholders' equity | -180 | -230 | -30 | 0 |
| TOTAL | $680 | $36,670 | $15,100 | $N/A |
| Total Liabilities And Equity | $10,820 | $43,330 | $24,400 | $0 |